10.04.2018
- Biogen and partner Samsung Bioepis have reached agreement with AbbVie regarding the commercialization of Imraldi, their biosimilar form of the latter’s blockbuster Humira. Specific...
23.08.2017
- South Korean biopharmaceutical company Samsung Bioepis is taking its first step into novel drug development with an agreement to partner Japan’s Takeda Pharmaceutical. The move...
